Ascendis Pharma A/s Earnings

Ascendis Pharma A/s’s revenue jumped 40.98% since last year same period to $245.18Mn in the Q4 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 14.77% jump in its revenue since last 3-months.

Ascendis Pharma A/s’s net profit jumped 13.57% since last year same period to $-33.25Mn in the Q4 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 45.49% jump in its net profits since last 3-months.

Ascendis Pharma A/s’s net profit margin jumped 38.69% since last year same period to -13.56% in the Q4 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 52.5% jump in its net profit margins since last 3-months.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current quarter stand at 0.39 - a 358.4% jump from last quarter’s estimates.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current year stand at 0.39.

Ascendis Pharma A/s’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Ascendis Pharma A/s has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.